Nuveen’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.5M Buy
76,595
+494
+0.6% +$12.1K ﹤0.01% 2383
2025
Q4
$2.04M Sell
76,101
-1,602
-2% -$41.3K ﹤0.01% 2288
2025
Q3
$2.07M Sell
77,703
-3,439
-4% -$88.8K ﹤0.01% 2281
2025
Q2
$1.86M Sell
81,142
-14,523
-15% -$360K ﹤0.01% 2335
2025
Q1
$2.77M Hold
95,665
﹤0.01% 2189
2024
Q4
$3.55M Sell
95,665
-112,307
-54% -$5.14M ﹤0.01% 2135
2024
Q3
$10.1M Sell
207,972
-93,617
-31% -$4.11M ﹤0.01% 1599
2024
Q2
$12.1M Buy
301,589
+114,098
+61% +$4.73M ﹤0.01% 1473
2024
Q1
$8.23M Sell
187,491
-2,356
-1% -$122K ﹤0.01% 1722
2023
Q4
$11.7M Sell
189,847
-164,112
-46% -$8.62M ﹤0.01% 1494
2023
Q3
$16.3M Sell
353,959
-20,560
-5% -$1.12M 0.01% 1163
2023
Q2
$21.5M Buy
374,519
+56,195
+18% +$2.49M 0.01% 1026
2023
Q1
$11.9M Sell
318,324
-65,681
-17% -$2.15M ﹤0.01% 1372
2022
Q4
$10.8M Sell
384,005
-32,602
-8% -$947K ﹤0.01% 1439
2022
Q3
$11.7M Sell
416,607
-174,217
-29% -$5.69M ﹤0.01% 1383
2022
Q2
$20.6M Buy
590,824
+114,149
+24% +$4.07M 0.01% 1031
2022
Q1
$16.9M Buy
476,675
+93,448
+24% +$2.65M 0.01% 1296
2021
Q4
$8.26M Buy
383,227
+9,175
+2% +$188K ﹤0.01% 1811
2021
Q3
$6.87M Sell
374,052
-45,085
-11% -$883K ﹤0.01% 2041
2021
Q2
$8.45M Buy
419,137
+243,749
+139% +$4.59M ﹤0.01% 1969
2021
Q1
$3.21M Sell
175,388
-11,172
-6% -$208K ﹤0.01% 2385
2020
Q4
$3.75M Sell
186,560
-18,626
-9% -$362K ﹤0.01% 2219
2020
Q3
$3.85M Buy
205,186
+20,651
+11% +$416K ﹤0.01% 2055
2020
Q2
$4.14M Buy
184,535
+46,580
+34% +$853K ﹤0.01% 2003
2020
Q1
$2.05M Sell
137,955
-390
-0.3% -$6.79K ﹤0.01% 2173
2019
Q4
$2.67M Sell
138,345
-165,026
-54% -$3.17M ﹤0.01% 2306
2019
Q3
$6.02M Sell
303,371
-271,412
-47% -$5.65M ﹤0.01% 1863
2019
Q2
$12.1M Buy
+574,783
New +$12M ﹤0.01% 1477

Other funds holding AMPH